Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients ; volume:6 ; number:1 ; day:8 ; month:2 ; year:2018 ; pages:1-9 ; date:12.2018
Acta Neuropathologica Communications ; 6, Heft 1 (8.2.2018), 1-9, 12.2018
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Urheber
-
Recasens, Ariadna
- Beteiligte Personen und Organisationen
-
Carballo-Carbajal, Iria
Parent, Annabelle
Bové, Jordi
Gelpi, Ellen
Tolosa, Eduardo
Vila, Miquel
SpringerLink (Online service)
- DOI
-
10.1186/s40478-018-0509-1
- URN
-
urn:nbn:de:1111-201804157509
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Recasens, Ariadna
- Carballo-Carbajal, Iria
- Parent, Annabelle
- Bové, Jordi
- Gelpi, Ellen
- Tolosa, Eduardo
- Vila, Miquel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease
Models of α-synuclein aggregation in Parkinson’s disease
α-Synuclein in parkinson's disease: pathogenic function and translation into animal models
Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Correction: Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease
Models of α-synuclein aggregation in Parkinson’s disease
α-Synuclein in parkinson's disease: pathogenic function and translation into animal models
Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Correction: Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease
Models of α-synuclein aggregation in Parkinson’s disease
α-Synuclein in parkinson's disease: pathogenic function and translation into animal models
Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Correction: Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease